Difference between revisions of "Tropisetron (Navoban)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
Warner-admin (talk | contribs) m (Text replacement - "http://www.cancer.gov" to "https://www.cancer.gov") |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
==Mechanism of action== | ==Mechanism of action== | ||
| − | [ | + | [https://www.cancer.gov/drugdictionary?CdrID=43507 From NCI]: "An indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in suppression of chemotherapy-and radiotherapy-induced nausea and vomiting." |
==Also known as== | ==Also known as== | ||
| Line 13: | Line 13: | ||
[[Category:Serotonin 5-HT3 antagonists]] | [[Category:Serotonin 5-HT3 antagonists]] | ||
| − | [[Category:EMA approved | + | [[Category:EMA approved in 1992]] |
[[Category:PMDA approved drugs]] | [[Category:PMDA approved drugs]] | ||
[[Category:KFDA approved drugs]] | [[Category:KFDA approved drugs]] | ||
Latest revision as of 20:21, 27 June 2024
Mechanism of action
From NCI: "An indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in suppression of chemotherapy-and radiotherapy-induced nausea and vomiting."
Also known as
- Code name: ICS 205-930
- Brand names: Abatoarin, Hensetron, Navoban, Setrovel